|
|
News Breaks | | | | January 14, 2013 | | 07:05 EDT |  | COV | Covidien opens patient enrollment for SWIFT PRIME study
Covidien announced the launch of a new study, SWIFT PRIME, which enrolled its first patient at the University at Buffalo. The new multi-center, randomized controlled trial will be one of the largest global studies to examine the adjunctive use of mechanical thrombectomy during the early stages of acute ischemic stroke onset. The SWIFT PRIME study will examine acute ischemic stroke patients treated with either intravenous tissue plasminogen activator alone or IV tPA in combination with Covidien’s Solitaire™ FR Revascularization Device, an overlapping stent-based technology that provides substantially improved clinical outcomes to the previous generation of devices. The study will also include an extensive health economics analysis. | |
|
News For COV From The Last 14 Days Check below for free stories on COV the last two weeks. |
|
|
| May 22, 2013 | | 07:00 EDT | | COV | Covidien announces positive results from clinical trial on endoscopic therapy
 Subscribe for More Information | | | May 20, 2013 | | 08:05 EDT | | COV | Covidien receives FDA 510(k) clearance for Nellcor pulse oximetry motion claims
Subscribe for More Information | | | May 16, 2013 | | 07:28 EDT |  | COV | I/O Central to host a conference
Subscribe for More Information | | | May 10, 2013 | | 06:16 EDT |  | COV | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information | |
|
|
|
|
|
|
